[Summary] 核酸干扰新药研发商
Sirnaomics是在中国及美国均占有重要市场地位的一家临床阶段RNA疗法生物制药公司,通过探索及开发创新药物,用于具有显着未满足医疗需求的人类疾病。临床开发管道专注于肿瘤学和纤维化适应症。WearethefirstandonlyclinicalstageRNAtherapeuticsbiopharmaceuticalcompanywithastrongpresenceinbothChinaandtheU.S.thatisdiscoveringanddevelopinginnovativedrugsforindicationswithsignificantunmetmedicalneedsandlargemarketopportunities.Wewerefoundedin2007withtheestablishmentofUSSirnaomicsinGaithersburg,Maryland.WearethefirstcompanytoachievepositivePhaseIIaclinicaloutcomesinoncologyforanRNAitherapeuticforou
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows